Can saltwater breathing ease a tough lung infection?

NCT ID NCT07647575

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests whether inhaling a salty mist (3% hypertonic saline) can improve breathing symptoms in people with nontuberculous mycobacterial (NTM) lung disease who haven't yet started antibiotics. About 262 adults will either start the saltwater treatment right away for 6 months or begin with normal saline for 3 months then switch. The main goal is to see if symptoms like cough and shortness of breath improve more with the stronger salt solution.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
3% hypertonic saline
What this could lead to
If it works, this could offer a simple, drug-free way to ease respiratory symptoms and improve mucus clearance in NTM lung disease.
What could go wrong
This is an early-stage trial with no phase designation, and the primary endpoint is symptom scores at just 3 months. The effect may be modest or not clinically meaningful.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRONCHIECTASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Taipei Veterans General Hospital

    RECRUITING

    Taipei, 11217, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.